Gupta, Vishal Kumar, Richa Giri, and Saurabh Agrawal. 2021. “Dipeptidyl Peptidase-4 Inhibitor (teneligliptin) Significantly Reduces Liver Fat Content and Delays Progression of Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients”. International Journal of Advances in Medicine 8 (12):1817-20. https://doi.org/10.18203/2349-3933.ijam20214516.